This is a working overview of triple agonist, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-03-29 and is reviewed periodically as new material appears.
Interpretation depends on study phase and duration. Phase 2 programs are powered for weight and safety signals, not for cardiovascular or renal outcomes, which require event-driven designs. Gastrointestinal events such as nausea, diarrhea, vomiting, and constipation are the most frequently reported adverse effects and tend to cluster around dose escalation. Small increases in heart rate have been described. Because follow-up after treatment discontinuation is limited, questions about weight regain and durability are open rather than answered.
Trial reports for this compound rely on a small set of repeated measures. Body weight is normally expressed as percent change from baseline at a fixed week, with absolute kilograms given secondarily. Glycemic endpoints include HbA1c, fasting glucose, and, in some protocols, continuous glucose monitoring summaries. Imaging endpoints such as MRI-derived proton density fat fraction quantify liver fat. Standardization matters because a percent change and a categorical responder analysis can tell different stories about the same dataset.
Body composition is assessed with dual-energy X-ray absorptiometry or comparable methods, which separate fat mass from lean mass. Reported losses include both compartments, and the ratio between them is a subject of ongoing analysis rather than a settled result. Waist circumference, blood pressure, and lipid panels are collected as supporting measures. Resting energy expenditure and substrate oxidation are measured in smaller mechanistic studies, where glucagon receptor activity is expected to matter. These substudies are typically short and small, so their findings carry wide uncertainty.
Acting as a triple agonist, the molecule binds the GLP-1, GIP, and glucagon receptors. GLP-1 activity slows gastric emptying and dampens appetite, while GIP signaling contributes to insulin sensitivity and fat metabolism. Glucagon receptor engagement raises energy expenditure and encourages fat breakdown, although it can also elevate blood glucose. Combining three pathways is intended to yield larger weight reduction than single or dual agonists, and researchers continue to examine how the balance among them shapes tolerability.
Clinical studies have reported notable reductions in body weight among participants. Early trials measured safety and explored several dose levels, and later studies tracked body-weight change over months of treatment. Investigators also monitor effects on glycemic markers, liver fat, and blood lipids. Because the compound is still in development, questions about long-term safety, cardiovascular outcomes, and durability after treatment ends remain open.
| Property | Value | Notes |
|---|---|---|
| Trial design | Randomized, double-blind, placebo-controlled | Frequently includes dose-escalation arms |
| Weight endpoint | Percent change from baseline | Reported at a prespecified week |
| Liver fat endpoint | MRI proton density fat fraction | Non-invasive imaging measure |
| Body composition method | Dual-energy X-ray absorptiometry | Separates fat mass from lean mass |
| Common adverse events | Nausea, diarrhea, vomiting | Reported most often during dose escalation |
Dissolution behavior depends on the amino acid sequence, the counterion content, and the buffer chosen. Many peptides disperse readily in water or mild aqueous buffers, while others require a small amount of organic co-solvent or a change in pH. Adsorption to plastic and glass surfaces can reduce the concentration of a solution over time, particularly at low concentrations. Filtration before analysis removes particulates, and aliquoting limits repeated freeze-thaw cycles that stress the material.
Research-grade peptide material is commonly supplied as a lyophilized powder, a form that limits degradation during transport and storage. Standard practice keeps such material cold and protected from light and moisture, with tighter conditions used for long-term archives. Once dissolved, solutions are generally considered less stable than the dry powder and are handled on shorter timescales. These established conventions derive largely from general peptide chemistry rather than from compound-specific evidence alone.
Identification and purity assessment typically rely on reversed-phase high-performance liquid chromatography, often paired with mass spectrometry. Mass measurement confirms the expected molecular mass and can reveal truncations or modifications. Peptide mapping and sequencing techniques provide sequence-level confirmation when needed. Because related peptide impurities can behave similarly in a single method, orthogonal techniques are usually combined. Reported purity values depend heavily on the method used and should be interpreted with that in mind.
Pharmacologically, retatrutide acts as a triple agonist at the glucagon-like peptide-1 receptor, the glucose-dependent insulinotropic polypeptide receptor, and the glucagon receptor. Activation of the first two receptors is associated with improved insulin secretion and reduced appetite. The glucagon receptor component is thought to increase energy expenditure, a mechanism that distinguishes this molecule from dual-agonist compounds. Researchers continue to investigate how the three activities interact and whether the combined profile offers advantages that justify additional clinical testing.
Several questions about the compound remain unresolved. The durability of weight reduction after treatment stops, the frequency of gastrointestinal side effects, and the long-term cardiovascular profile are topics of ongoing study. Regulatory submissions and phase 3 trial outcomes have not been fully reported in the public literature. Because most available data come from controlled trials rather than general-population use, conclusions about effectiveness outside study settings are provisional. The distinction between established findings and open questions matters when interpreting early coverage of the drug.
Retatrutide is an investigational peptide developed by a pharmaceutical company as a multi-receptor agonist for treating obesity and type 2 diabetes. The compound emerged from research into gut-hormone analogues that act on several receptors simultaneously rather than on a single target. Early preclinical work examined how combined activity at three distinct receptors might produce greater metabolic effects than single-receptor compounds. Published phase 2 results have described substantial reductions in body weight among participants, although the compound remains unapproved in most jurisdictions as of the mid-2020s.
In May 2023, the FDA approved the iLet Bionic Pancreas system for people with Type 1 diabetes of six years and older. The device uses a closed-loop system to deliver both insulin and glucagon in response to sensed blood glucose levels. The 4th generation iLet prototype, presented in 2017, is around the size of an iPhone, with a touchscreen interface. It contains two chambers for both insulin and glucagon, and the device is configurable for use with only one hormone, or both. A 440-patient study of type I diabetes ran in 2020 and 2021 using a device configuration that delivered only insulin in comparison to standard of care; device use led to better circulating glucose control (measured by continuous monitoring) and a reduction in glycated hemoglobin (versus no change for the standard of care group). However, the incidence of severe hypoglycemic events was more than 1.5 times higher among device users versus standard care patients. There are several non-commercial, non-FDA approved DIY options, using open source code, including OpenAPS, Loop, and/or AndroidAPS.
CDs and DVDs have a polycarbonate surface and metal reflective layer which allow for storage and retrieval of information. The metal film is sometimes made of pure gold which is highly stable and has ideal optical properties. The metal can act as a substrate which allows compounds to bind to it. This alters the reflective and refractive properties of the disk. Disk reading is based on capturing analog signals with the disk drive. The signals are indicative of how much analyte is in a sample. Because the disk spins, the platform has the ability to drive the sample through it through microfluidic channels and for multiple steps to be performed, allowing the possibility for sample preparation and more than one analysis to be conducted during a single run. CD/DVD based assays could potentially be used for any immunoassay already in use and many assays used in analytical chemistry, as long as analytes have a corresponding probe, are soluble, and are large enough to alter the angle of incident.
CoviVac – COVID vaccine Cytestrol acetate – antiestrogen, cytostatic antineoplastic agent Deltaran (delta sleep-inducing peptide) – alcohol withdrawal treatment Dilept (GZR-123) – antipsychotic, neurotensin analogue Diucifon – leprostatic agent Emoxypine (Mexidol; Mexifin) – actoprotector, antioxidant EpiVacCorona – COVID vaccine Eprobemide (Befol) – antidepressant, reversible inhibitor of monoamine oxidase A Ethacizine (ethacyzine; Ethacizin) – antiarrhythmic agent Fabomotizole (Afobazole) – anxiolytic Feprosidnine (Sydnophen) – amphetamine derivative, psychostimulant Fluacizine (Phtorazisin) – tricyclic antidepressant, phenothiazine Fluorothiazinone (CL-55; Ftortiazinon) – investigational antibiotic Fotretamine (Fotrin) – alkylating antineoplastic agent, immunosuppressant Gamofen (gamophen; amphetamine–GABA) – amphetamine derivative, GABATooltip γ-aminobutyric acid analogue, central agent, central depressant Gidazepam (hydazepam, hidazepam) – atypical benzodiazepine, anxiolytic, TSPOTooltip translocator protein agonist/ligand Gludantan (gludantane) – adamantane, antiparkinsonian agent, antidepressant Glufimet (RGPU-238; dimethyl 3-phenylglutamate) – GABATooltip γ-aminobutyric acid and phenibut analogue Glutaron (RGPU-135; neuroglutamine, neuroglutam; β-phenylglutamate; 3-phenylglutamate) – glutamate analogue, psychostimulant, antidepressant, anxiolytic, neuroprotective Hemantane (hymantane) – adamantane, antiparkinsonian agent Hopantenic acid (homopantothenic acid; N-pantoyl-GABA; Pantogam) – central depressant, GABATooltip γ-aminobutyric acid analogue Ipidacrine (Neiromidin) – acetylcholinesterase inhibitor Latrepirdine (dimebolin; Dimebon) – antihistamine, antiserotonergic, nootropic Mecigestone (pentarane B) – progestin Megestrol caproate (MGC) – progestin Meldonium (Mildronate) – anti-ischemia agent Menthyl isovalerate (validolum; Extravalerianic, Validol, Valofin, Menthoval) – anxiolytic Mesocarb (Sidnocarb, Sydnocarb, Synocarb) – amphetamine derivative, psychostimulant Methylphenatine – amphetamine derivative, psychostimulant Methylphenylpiracetam – racetam, sigma σ1 receptor positive allosteric modulator α-Methyltryptamine (αMT; Indopan) – tryptamine derivative, antidepressant Metralindole (Inkazan) – antidepressant, reversible inhibitor of monoamine oxidase A Moracizine (moricizine; Ethmozine) – antiarrhythmic agent Nooglutyl (Nooglutil; N-5-hydroxynicotinoyl-L-glutamate) – nootropic Orenetide (BP101; Libicore; Desirix; Thr-Lys-Pro-Arg-Pro) – investigational small peptide, sexual enhancer Pabofen (pabophen; amphetamine–PABA) – amphetamine derivative, antihypoxic agent Pentarane A (D'6-pentarane) – progestin Phemerazole (femerazol; 5-phenyl-3-methylpyrazole) – sedative, hypnotic, anticonvulsant, muscle relaxant, mammary stimulant Phenatine (phenatin; Fenatine; amphetamine–niacin; N-nicotinoylamphetamine) – amphetamine derivative, psychostimulant, hypotensive agent Phenazepam – benzodiazepine, anxiolytic, sedative, hypnotic Phenibut (β-phenyl-GABA; Anvifen, Fenibut, Noofen; Citrocard, RGPU-147) – central depressant, anxiolytic, GABATooltip γ-aminobutyric acid analogue, gabapentinoid N-Phenylacetyl-L-prolylglycine ethyl ester (omberacetam; Noopept) – nootropic, racetam, cyclic glycine-proline prodrug Phenylphenamine (phenylamphetamine) – amphetamine derivative Phenylpiracetam (fonturacetam; Phenotropil, Actitropil, Carphedon) – psychostimulant, nootropic, racetam Phenylpiracetam hydrazide (fonturacetam hydrazide) – anticonvulsant, racetam Picamilon (N-nicotinoyl-GABA, pycamilon, and pikamilon) – anxiolytic, GABATooltip γ-aminobutyric acid analogue Pipofezine (Azafen, Azaphen) – tricyclic antidepressant Pirlindole (Lifril, Pyrazidol) – antidepressant, reversible inhibitor of monoamine oxidase A, serotonin–norepinephrine reuptake inhibitor Polymethylsiloxane polyhydrate (PMSPH; methylsilicic acid hydrogel; Enterosgel) – enterosorbent Propylphenamine (propylamphetamine; possibly N-propylamphetamine) – amphetamine derivative Prospidium chloride (prospidine) – cytostatic, anti-inflammatory agent Pyridoxiphen (amphetamine–pyridoxine; pyridoxylamphetamine) – amphetamine derivative, sympatholytic, hypotensive agent Quifenadine (Phencarol, Fencarol) – antihistamine RGPU-95 (p-chlorophenylpiracetam) – antidepressant, anxiolytic, racetam RGPU-207 (cyclic GABA derivative) – GABATooltip γ-aminobutyric acid analogue, mitochondrial modulator, racetam RGPU-260 – GABATooltip γ-aminobutyric acid analogue, cardiac stimulant Riamilovir (Triazavirin) – antiviral RU-1205 – analgesic, kappa opioid receptor agonist Selank – tuftsin analogue, nootropic, anxiolytic Semax – ACTHTooltip adrenocorticotropic hormone fragment analogue, nootropic, neuroprotective, neurorestorative Sodium polydihydroxyphenylene thiosulfonate (Hypoxen) – antihypoxic agent Sputnik Light – COVID vaccine Sputnik V – COVID vaccine Sulfozinum (sulfazin) – pyrogenic and pain-inducing agent used in psychiatry, for instance psychosis Temgicoluril (tetramethylglycoluril; Adaptol, Mebicar, Mebicarum, Mebikar) – anxiolytic Testifenon (testiphenon, testiphenone, chlorphenacyl dihydrotestosterone ester) – androgen/anabolic steroid, cytostatic antineoplastic agent Tetrindole – antidepressant, reversible inhibitor of monoamine oxidase A Thiophenatine (N-thionicotinoylamphetamine) – amphetamine derivative Tipindole – serotonin antagonist and monoamine oxidase inhibitor Tolibut (β-(4-methylphenyl)-GABA)) – anxiolytic, analgesic, neuroprotective, GABATooltip γ-aminobutyric acid and phenibut analogue Traneurocin (cycloprolylglycine; CPG; NA-831) – racetam-like neuroprotective, neurogenic, nootropic, and anxiolytic Trimeperidine – opioid analgesic Umifenovir (Arbidol) – antiviral Vishnevsky liniment – topical wound medication Phenamine (Fenamin), a psychostimulant, is not specifically a Russian drug but is rather the Russian name for amphetamine.
=== Synthetic analogues === Many vitamin B1 analogues, such as Benfotiamine, fursultiamine, and sulbutiamine, are synthetic derivatives of thiamine. Most were developed in Japan in the 1950s and 1960s as forms that were intended to improve absorption compared to thiamine. Some are approved for use in some countries as a drug or non-prescription dietary supplement for treatment of diabetic neuropathy or other health conditions.
Argentine diplomacy considered the interference of the Peruvians in the war against Paraguay, as well as in the internal affairs of the Argentine state, as something of less relevance compared to the interference of the Chileans, despite the fact that Peru and Chile collaborated (until end of 1867) against the objectives of the Triple Alliance, which would demonstrate discriminatory conduct of Argentine diplomacy against the Peruvians, portrayed as servile puppets and marionette of the Chileans. Meanwhile, Argentine diplomats came to accuse Chile of meddling in Bolivian politics, manipulating them to carry out anti-Argentine policies; and support the Revolution of the Colorados, carried out by federal opponents of the government of President Mitre. The dissident press of Argentina and Uruguay (opposed to their governments and in solidarity with Chile and Peru), which questioned the foreign policy carried out by their foreign ministries, was attacked by their respective governments, being restricted and even prohibited from circulating in Argentina. Meanwhile, the newspapers of the Spanish immigrant communities, extolling the action of the Spanish Navy in the South Pacific against the Peruvian and Chilean navies (during the Spanish-South American War), circulated freely in the cities. Argentine, which evidenced anti-Peruvian and anti-Chilean biases. Another example of these biases occurs when analyzing and comparing the newspapers El Mercurio of Valparaíso and La Nación Argentina of Buenos Aires.
Sources: en.wikipedia.org
Andrew Samuels argues that his remarks on the "Aryan unconscious" and the "corrosive character" of Freud's "Jewish gospel" demonstrate a form of antisemitism "fundamental to the structure of Jung's thought" but also argues that there is a "pioneering nature of Jung's contributions" and that "his intuition of the importance of exploring difference remains intact." In 1934, in a circular for the society, Jung also drew attention to its constitution, which permitted individual doctors to join directly rather than through one of the national affiliated societies. This meant that German Jewish doctors could maintain their professional status as individual members of the international body, even though they were excluded from the German affiliate, as well as from other German medical societies operating under the Nazis. Jung said, "The main point is to get a young and insecure science into a place of safety during an earthquake." On the other hand, also in 1934, Jung wrote in a Swiss publication, the Neue Zürcher Zeitung, that he experienced "great surprise and disappointment" when the Zentralblatt associated his name with the pro-Nazi statement. He did not end his relationship with the Zentralblatt at this time, but he did arrange the appointment of a new managing editor, Carl Alfred Meier of Switzerland. For the next few years, the Zentralblatt under Jung and Meier maintained a position distinct from that of the Nazis in that it continued to acknowledge the contributions of Jewish doctors to psychotherapy.
=== 1990s === In the early 1990s, Wolverine featured as a prominent character in X-Men vol. 2, initially written by Claremont and illustrated by Jim Lee. The first issue of this series is the highest selling comic book issue in history, selling more than eight million copies. During this period, Wolverine regularly appeared in cover stories for the anthology series Marvel Comics Presents, due to a mandate from Marvel's sales department, which noticed that sales of the series were always higher for issues in which Wolverine was featured. Among these stories was "Weapon X", written and drawn by Windsor-Smith, serialized in issues #72–84 (1991). The story depicts Wolverine's past, how adamantium was grafted to his skeleton, and his experience of extreme psychological and physical trauma. Subsequent Wolverine stories in Marvel Comics Presents were often illustrated by Sam Kieth and had a more psychedelic aesthetic and storytelling style. Wolverine returned to his original blue-and-yellow costume in this period. Wolverine starred in a popular new story arc in X-Men after Claremont's departure, plotted by Byrne and Lee, that revealed more about Wolverine's past and the consequences of the Weapon X program.
Stanley (also known as Port Stanley) is the capital city of the Falkland Islands. It is located on the island of East Falkland, on a north-facing slope in one of the wettest parts of the islands. At the 2021 census, the city had a population of 2,974, accounting for 81% of the entire population of the Falkland Islands, which was 3,662 on Census Day – 10 October 2021. Stanley is represented by five of the eight elected members of the Legislative Assembly of the Falkland Islands: Stacy Bragger, Barry Elsby, Mark Pollard, Roger Spink, and Leona Vidal Roberts. An elected Town Council of Stanley existed from 1948 to 1973. On 14 June 2022, during the Platinum Jubilee Civic Honours, Stanley received letters patent, formally awarding it city status. It is the southernmost capital of a self-governing territory or state.
== Methods to study condensates == A number of experimental and computational methods have been developed to examine the physico-chemical properties and underlying molecular interactions of biomolecular condensates. Experimental approaches include phase separation assays using bright-field imaging or fluorescence microscopy, and fluorescence recovery after photobleaching (FRAP), as well as rheological analysis of phase-separated droplets. Computational approaches include coarse-grained molecular dynamics simulations and circuit topology analysis.
This must be especially the case for LCRs found in highly expressed proteins, since they should also have a great impact on the energy burden of protein translation. Thus, any prokaryotic LCRs that constitute evolutionary accidents with no functional significance should not be fixed by genetic drift and consequently should not demonstrate any levels of conservation among moderately distant evolutionary relatives. On the contrary, any LCR found among homologs of several moderately distant prokaryotic species should very probably reserve a functional role.
Sources: en.wikipedia.org
Nutrition-related results A study reports results of the first longevity caloric restriction (CR) trial, CALERIE, finding that two years of nonintermittent CR slowed the pace of aging as measured by one of three aging clocks (modest DunedinPACE effects). Development and application of aging clocks and combination therapies A study reports the development of deep learning software using anatomic magnetic resonance images to estimate brain age with the highest accuracy for AI so far, including detecting early signs of Alzheimer's disease and varying neuroanatomical patterns of neurological aging. A study shows DNA methylation aging clocks could be useful indicators of health while social factors – such as health behaviors and poverty – are at least as good predictors and e.g. can better predict cognitive functioning. Around February, Bryan Johnson's Project Blueprint for one of the first comprehensive, possibly largely public, self-experimentations of a comprehensive combination therapy informed by the large scientific corpus on the topic and organ measurements to maximally reverse biological age and (epigenetic) aging markers achieves substantial media attention, with such activities previously largely reserved to biohackers without resources and means to evaluate effects. The pan-mammalian epigenetic clock is a molecular biomarker designed to measure the age of all mammalian tissues and species using cytosine methylation in highly conserved DNA regions. A study indicates chest radiographs evaluated using AI could be a performant biomarker for aging clocks.
Genetic studies on the Sinhalese are part of population genetics investigating the ancestral origins of the Sinhalese people. A 2025 study utilizing whole genome sequencing has shown that the Sinhalese exhibit a close genetic proximity to South Indian populations and other groups within Sri Lanka, such as Sri Lankan Tamils and the Vedda. Modern genomic analysis suggests that the genetic contribution from Western Indian (Maratha) sources is more predominant than that from North Indian populations, though shared ancestral components exist across the broader South Asian subcontinent.
== Research and development == In November 2013, Discovery Laboratories began its phase II clinical program of aerosolized KL4 since U.S. Food and Drug Administration (FDA) had cleared the investigational new drug (IND) application. The phase II consists of two steps to evaluate the safety and tolerability of the drug and determine the optimal dose for premature infants with respiratory distress syndrome (RDS) In October 2013, Discovery Laboratories received the agreement of updating Surfaxin (lucinactant) Intratracheal Suspension from the U.S. Food and Drug Administration (FDA) to prevent respiratory distress syndrome (RDS) in premature infants. In September 2012, Discovery Laboratories started the four research projects to explore the KL4 surfactant technology for acute lung injury (ALI). These projects are funded through government-sponsored, biodefense-related initiatives under the Project Bioshield Act of 2004 and the Pandemic and All-Hazards Preparedness Act of 2006.
linkage The tendency of DNA sequences which are physically near to each other on the same chromosome to be inherited together during meiosis. Because the physical distance between them is relatively small, the chance that any two nearby parts of a DNA sequence (often loci or genetic markers) will be separated on to different chromatids during chromosomal crossover is statistically very low; such loci are then said to be more linked than loci that are farther apart. Loci that exist on entirely different chromosomes are said to be perfectly unlinked. The standard unit for measuring genetic linkage is the centimorgan (cM).
Sources: en.wikipedia.org
A responder analysis counts participants who cross a threshold, such as five or ten percent weight loss. It complements average percent change by showing how widely results are distributed. The two measures can diverge when a subset of participants loses a large amount.
Mechanistic measures such as energy expenditure and liver fat change come from small substudies and should be read as preliminary. Long-term clinical outcomes are not yet available. Average weight loss figures are better supported than explanations for how the loss is achieved.
Endpoints reported at different weeks, in different baseline BMI ranges, or under different dose-escalation schedules are not directly comparable. Studies in type 2 diabetes often show smaller weight changes than studies in obesity without diabetes. Reporting the population alongside the number keeps comparisons honest.
It is a synthetic peptide classified as a triple receptor agonist. It engages the GLP-1, GIP, and glucagon receptors at once. It is investigated for metabolic and weight-related conditions rather than approved for general use.